Drug intelligence / Profile preview

realgar quantum dots

Development stage
Preclinical
Lead developer
Zunyi Medical University
Modality
Inorganic Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
In Vitro, Intravenous (potential/experimental)
01

Overview

Realgar quantum dots are nanoscale particles (~5.5 nm) derived from realgar (arsenic sulfide, As4S4), engineered to improve water solubility and bioavailability compared to bulk realgar. Realgar quantum dots exhibit significant cytotoxicity against various cancer cells, particularly hepatocellular carcinoma (HepG2), through mechanisms involving apoptosis and necrosis. Specifically, they induce endoplasmic reticulum stress, upregulate the stress genes CHOP (C/EBP homologous protein) and GRP78 (glucose-regulated protein 78), and disrupt mitochondrial membrane potential, leading to an increase in pro-apoptotic Bax and a decrease in anti-apoptotic Bcl-2 protein levels. In preclinical models, RQDs have demonstrated antitumor activity without overt toxicity at effective doses. These particles are used primarily in cancer research and not currently as approved pharmaceutical products[1].

Other names
realgar quantum dotsRQDs
02

Targets

BAX (Apoptosis regulator BAX)ChoP (Phosphorylcholine)HSPA5 (Heat shock protein family A member 5)

Beyond the preview

Go deeper on realgar quantum dots.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on realgar quantum dots.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call